Noxopharm Ltd Cash Flow-to-Debt Ratio
Noxopharm Ltd cash flow-to-debt ratio. Noxopharm Ltd (NOX) has a Cash Flow-to-Debt Ratio of -0.46x as of December 2025, meaning its operating cash flow of AU$-2.71 Million could theoretically repay 0% of its total liabilities (AU$5.88 Million) in one year. Check Noxopharm Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Noxopharm Ltd (2016–2025)
Cash flow-to-debt ratio of Noxopharm Ltd from 2016 to 2025. Historical debt coverage capacity for Noxopharm Ltd across 10 annual periods. Check how aggressively does Noxopharm Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Noxopharm Ltd Cash Flow-to-Debt Ratio by Year (2016–2025)
Noxopharm Ltd cash flow-to-debt ratio by year from 2016 to 2025. Year-by-year debt coverage analysis for Noxopharm Ltd. For the full cash flow conversion analysis, see Noxopharm Ltd (NOX) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.50x | AU$-5.82 Million | AU$3.89 Million | ▼ -181.9% |
| 2024 | -0.53x | AU$-684.31K | AU$1.29 Million | ▲ +94.9% |
| 2023 | -10.37x | AU$-10.95 Million | AU$1.06 Million | ▼ -87.0% |
| 2022 | -5.55x | AU$-13.73 Million | AU$2.48 Million | ▼ -343.6% |
| 2021 | -1.25x | AU$-8.85 Million | AU$7.08 Million | ▲ +19.2% |
| 2020 | -1.55x | AU$-11.14 Million | AU$7.19 Million | ▲ +8.9% |
| 2019 | -1.70x | AU$-9.78 Million | AU$5.75 Million | ▲ +17.6% |
| 2018 | -2.06x | AU$-9.08 Million | AU$4.40 Million | ▲ +74.5% |
| 2017 | -8.08x | AU$-2.92 Million | AU$361.04K | ▼ -284.8% |
| 2016 | -2.10x | AU$-549.72K | AU$261.72K | — |